TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 02/10/26

2026-02-10 08:30:33 ET Improved efficacy, faster onset, and scalable platforms drive investor interest in next-gen CNS assets New York, NY –February 10, 2026 – Market News Updates News Commentary – Novel serotonergic agonists (“NSAs”...

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1 The Prescriptio...

2026-02-09 10:34:12 ET More on Takeda Pharmaceutical Takeda Tests New Highs, But Struggles To Find Entyvio Successor Takeda Pharmaceutical Company Limited (TAK) Q3 FY2025 Earnings Call Transcript Takeda Pharmaceutical Company Limited (TAK) Presents at 44th Annual J.P...

2026-02-05 14:55:55 ET Image source: The Motley Fool. Thursday, Oct. 30, 2025 at 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-05 08:15:45 ET More on Alvotech, Takeda Pharmaceutical Takeda Tests New Highs, But Struggles To Find Entyvio Successor Takeda Pharmaceutical Company Limited (TAK) Q3 FY2025 Earnings Call Transcript Alvotech: Why FDA Delays Don't Break The Bull Case Al...

2026-02-02 15:47:26 ET Today, I am putting Harmony Biosciences Holdings, Inc. ( HRMY ) in the spotlight for the first time since my last article of this reasonable valued biopharma firm back in June of last year. The stock has moved up slightly since that research was po...

2026-01-30 14:10:18 ET We last touched on Takeda Pharmaceutical Company Limited ( TAK ) back in May, at the end of the previous fiscal year. The stock was beaten down, and while we were expecting 2025 to be a challenge, I rated it a buy because it was a chance to buy exposure to...

2026-01-30 00:43:50 ET Takeda Pharmaceutical Company Limited (TAK) Q3 FY2025 Earnings Call January 29, 2026 5:30 AM EST... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TAK) Q3 FY2025 Earnings Call Transcript

2026-01-29 16:52:28 ET Takeda Pharmaceutical Company Limited (TAK) Q3 2026 Earnings Call January 29, 2026 5:30 AM EST... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TAK) Q3 2026 Earnings Call Transcript

Nomura Research Institute Ltd. ADR (NRILY) is expected to report $0.33 for Q3 2026 Arthur J. Gallagher & Co. (AJG) is expected to report $2.35 for Q4 2025 STMicroelectronics N.V. (STM) is expected to report $0.27 for Q4 2025 Middlefield Banc Corp. (MBCN) is expected to report $0.6...